Evaluating the Usefulness and Ease of Use of a Next-Generation-Connected Drug Delivery Device for Growth Hormone Therapy: Qualitative Study of Health Care Professionals' Perceptions.

José I. Labarta Paul Dimitri Matthew Keiser Ekaterina Koledova Octavio Rivera Romero

Published in: JMIR human factors (2023)

This study explored the perceived value of the EP3 autoinjector device for the treatment of GHD by HCPs. HCPs rated the new capabilities of the device as having substantial improvements and concluded that it was highly recommendable for clinical practice. EP3 will enhance decision-making and allow for more personalized care of patients receiving r-hGH.

Keyphrases

healthcare
growth hormone
drug delivery
clinical practice
decision making
palliative care
mental health
primary care
social support
physical activity
depressive symptoms
quality improvement
cancer therapy
affordable care act
combination therapy
replacement therapy
drug release